Lexicon Pharmaceuticals

$1.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+5.45%) As of 10:42 AM EST today

Why Robinhood?

You can buy or sell LXRX and other stocks, options, and ETFs commission-free!

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. The listed name for LXRX is Lexicon Pharmaceuticals, Inc. Common Stock.

CEO
Lonnel Coats
Employees
184
Headquarters
The Woodlands, Texas
Founded
1995
Market Cap
179.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
13.05M
High Today
$1.54
Low Today
$1.44
Open Price
$1.48
Volume
621.20K
52 Week High
$5.33
52 Week Low
$1.03

Collections

LXRX Earnings

-$0.77
-$0.27
$0.23
$0.73
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like